Oxidized low density lipoprotein (Human) (Human ox-LDL) is a key pro-atherosclerotic signal regulator and apoptosis inducer. Oxidized low density lipoprotein (Human) mediates cellular uptake and signal transduction by binding to TLR4 and scavenger receptors such as SR-A, CD36, LOX-1, and localizes to atherosclerotic lesion sites. Oxidized low density lipoprotein (Human) mediates Apoptosis activity through the ligand-dependent Fas receptor pathway and co-activated TNF receptors I/II, induces the formation of active subunits of Caspase 2, 3, 6, 8, and simultaneously activates multiple signaling pathways including MAPK, NFκB, p53 and AP-1 complexes. Oxidized low density lipoprotein (Human) exerts cytotoxicity by upregulating the pro-apoptotic protein Bad and downregulating the level of the anti-apoptotic protein Bcl-2, inducing foam cell formation and monocyte chemotaxis. Oxidized low density lipoprotein (Human) also stimulates vascular cell proliferation, cytokine production and platelet activation, while inhibiting endothelium-dependent vasodilation. Oxidized low density lipoprotein (Human) can be used in atherosclerosis-related research.